CNBC's Jim Cramer said Moderna's expanding pipeline in treatments for cancer and other diseases provides a compelling ...
Moderna shares rose nearly 20% after Science Day, driven partly by a short squeeze, while its mRNA pipeline beyond vaccines ...
The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.
Just The News on MSNOpinion
After years of requests, feds still won't explain plunge in people taking COVID vax second dose
Administration has repeatedly irked presumed allies on COVID vaccine policy, from its silence on reported 32 million ...
Adults who received the updated mRNA-1273 COVID-19 vaccine experienced a lower risk for hospitalization compared with NVX-CoV2705 recipients.
Onshore mRNA manufacturing is emerging as critical national infrastructure, strengthening Australia’s pandemic preparedness.
The influence of the alcohol industry on policy, AI Claude for scientists, and more health news from Morning Rounds ...
Two of the world’s most innovative cities have the same name and completely opposite problems. That is leading to closer ...
BarcelonaThe testimony of those responsible for the covid vaccination of national police and Civil Guard agents in Catalonia has been a bucket of cold water for police unions that accuse former heads ...
Insider's new investigative reporting project reveals the depths of lawmakers' conflicts-of-interest, potential self-dealing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results